{"database": "lobbying", "table": "lobbying_activities", "rows": [[508829, "50319651-ed2c-4f80-8e38-d84f2651aca8", "MM", "NATIONAL VENTURE CAPITAL ASSOCIATION", 21687, "NATIONAL VENTURE CAPITAL ASSOCIATION", 2007, "mid_year", "MED", "*\r\n\r\n\r\n\r\n\r\nFDA Reform User Fee Reauthorization S.1082 and HR 2900 to reauthorize the FDA user fees for prescription drugs nad medical devices; to reform the FDA regulatory process.\r\nBiogenerics Pathway HR 1038 and S 623 - Access to Life Savings Medicine Act\r\nHR 1956, Patient Protection and Innovative Biologics Medicine Act; S. 1695 Biologics Price Competition Act\r\nS.1859 and HR 3161 FY08 FDA Appropriations", "Energy, Dept of,HOUSE OF REPRESENTATIVES,Patent & Trademark Office (PTO),Securities & Exchange Commission (SEC),SENATE,Small Business Administration (SBA),White House Office", 0, 0, "2007-08-01T14:52:18-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["508829"], "units": {}, "query_ms": 0.5496279918588698, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}